These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2219678)

  • 41. 5-Methylated naloxone, naltrexone, oxymorphone, and their 14-O-methyl ethers.
    Schmidhammer H; Leander JD; Mayer-Valkanover K; Nussbaumer C; Schmidt C; Schoepp DD; Schratz A; Walla-Kugler M
    Prog Clin Biol Res; 1990; 328():41-4. PubMed ID: 2154800
    [No Abstract]   [Full Text] [Related]  

  • 42. Sedative and echocardiographic effects of dexmedetomidine combined with butorphanol in healthy dogs.
    Kellihan HB; Stepien RL; Hassen KM; Smith LJ
    J Vet Cardiol; 2015 Dec; 17(4):282-92. PubMed ID: 26546490
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Focal kappa-opioid receptor-mediated dependence and withdrawal in the nucleus paragigantocellularis.
    Sinchaisuk S; Ho IK; Rockhold RW
    Pharmacol Biochem Behav; 2002 Dec; 74(1):241-52. PubMed ID: 12376173
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevention of late fentanyl-induced respiratory depression after the injection of opiate antagonists naltrexone and S-20682: comparison with naloxone.
    Freye E; Hartung E; Kaliebe S
    Br J Anaesth; 1983 Jan; 55(1):71-7. PubMed ID: 6129881
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antiemetic activity of butorphanol against cisplatin-induced emesis in ferrets and dogs.
    Schurig JE; Florczyk AP; Rose WC; Bradner WT
    Cancer Treat Rep; 1982 Oct; 66(10):1831-5. PubMed ID: 6889914
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of the effects of naloxone on recovery time and quality after ketamine-medetomidine-butorphanol anesthesia in servals (Leptailurus serval).
    Moresco A; Larsen RS; Lassiter AJ
    J Zoo Wildl Med; 2009 Jun; 40(2):289-95. PubMed ID: 19569475
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of medetomidine-midazolam, acepromazine-butorphanol, and midazolam-butorphanol on induction dose of thiopental and propofol and on cardiopulmonary changes in dogs.
    Kojima K; Nishimura R; Mutoh T; Hong SH; Mochizuki M; Sasaki N
    Am J Vet Res; 2002 Dec; 63(12):1671-9. PubMed ID: 12492281
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of a combination of acepromazine maleate and butorphanol tartrate on conventional and two-dimensional speckle tracking echocardiography in healthy dogs.
    Santarelli G; López JT; Del Palacio JF
    Am J Vet Res; 2017 Feb; 78(2):158-167. PubMed ID: 28140649
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cardiac troponin I concentrations following medetomidine-butorphanol sedation in dogs.
    Singletary GE; Saunders AB; Saunders WB; Suchodolski JS; Steiner JM; Fosgate GT; Hartsfield SM
    Vet Anaesth Analg; 2010 Jul; 37(4):342-6. PubMed ID: 20636565
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of opiate antagonists and their quaternary analogues on nucleus accumbens self-stimulation.
    Trujillo KA; Belluzzi JD; Stein L
    Behav Brain Res; 1989 Jun; 33(2):181-8. PubMed ID: 2548531
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nalmefene: a long-acting opioid antagonist. Clinical applications in emergency medicine.
    Wang DS; Sternbach G; Varon J
    J Emerg Med; 1998; 16(3):471-5. PubMed ID: 9610980
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-acting opiate agonists and antagonists: 14-hydroxydihydromorphinone hydrazones.
    Pasternak GW; Hahn EF
    J Med Chem; 1980 Jun; 23(6):674-6. PubMed ID: 6156240
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evidence for the delivery of narcotic antagonists to the colon as their glucuronide conjugates.
    Simpkins JW; Smulkowski M; Dixon R; Tuttle R
    J Pharmacol Exp Ther; 1988 Jan; 244(1):195-205. PubMed ID: 3335997
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of the sedative effects of nalbuphine and butorphanol, alone or in combination with acepromazine in dogs.
    Gomes VH; Oliveira RL; Marques JL; Coelho CM; Silva MF
    Vet Anaesth Analg; 2018 Jan; 45(1):68-72. PubMed ID: 29183660
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The cardiopulmonary effects of a peripheral alpha-2-adrenoceptor antagonist, MK-467, in dogs sedated with a combination of medetomidine and butorphanol.
    Salla K; Restitutti F; Vainionpää M; Junnila J; Honkavaara J; Kuusela E; Raekallio M; Vainio O
    Vet Anaesth Analg; 2014 Nov; 41(6):567-74. PubMed ID: 24674053
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of hydromorphone or oxymorphone, with or without acepromazine, on preanesthetic sedation, physiologic values, and histamine release in dogs.
    Smith LJ; Yu JK; Bjorling DE; Waller K
    J Am Vet Med Assoc; 2001 Apr; 218(7):1101-5. PubMed ID: 11318359
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sedative and cardiorespiratory effects of medetomidine, medetomidine-butorphanol, and medetomidine-ketamine in dogs.
    Ko JC; Fox SM; Mandsager RE
    J Am Vet Med Assoc; 2000 May; 216(10):1578-83. PubMed ID: 10825944
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of morphine, naloxone, buprenorphine, butorphanol, haloperidol and imipramine on morphine withdrawal signs in cynomolgus monkeys.
    Fukase H; Fukuzaki K; Koja T; Nagata R; Lukas SE
    Psychopharmacology (Berl); 1994 Dec; 116(4):396-400. PubMed ID: 7701039
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of three midazolam-xylazine mixtures. Preliminary trials in dogs.
    Tranquilli WJ; Gross ME; Thurmon JC; Benson GJ
    Vet Surg; 1990; 19(2):168-72. PubMed ID: 2110392
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intranasal butorphanol-induced apraxia reversed by naloxone.
    Gora-Harper ML; Sunahara JF; Gray MS
    Pharmacotherapy; 1995; 15(6):798-800. PubMed ID: 8602392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.